Clinirem Sp. z o.o.
- Address
- Wielicka 42 Lokal U 3, 02-657 Warsaw, Poland
Immune System Diseases
Clinirem Sp. z o.o. advances the study of autoimmune neuropathies and related disorders, seeking to test innovative therapies and enhance patient quality of life.
- Evaluation of novel biologics for autoimmune neuropathies
- Safety assessment of targeted agents in generalized myasthenia gravis
- Comparative effectiveness of immunoglobulin versus emerging treatments
A dedicated team of seven investigators collaborates to generate safer, more effective options for individuals affected by immune‑mediated diseases.
Musculoskeletal Diseases
Research at the Warsaw site focuses on muscle‑strength impairments linked to motor neuropathies, aiming to identify therapies that restore functional ability.
- Improving muscle strength in multifocal motor neuropathy
- Assessing empasiprubart versus IVIg for enhanced neuromuscular function
- Exploring mechanisms of inflammatory muscle weakness
The program integrates clinical expertise and patient‑centered outcomes to broaden treatment choices for musculoskeletal conditions.
Nervous System Diseases
The center conducts trials on migraine and peripheral nerve disorders, evaluating both preventive and acute interventions to reduce disease burden.
- Prophylactic treatment options for migraine
- Acute migraine pain‑relief strategies
- Preventing relapse in chronic inflammatory demyelinating polyneuropathy
With a multidisciplinary team, the site aims to deliver evidence‑based solutions that improve daily functioning for patients with neurological disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinirem Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 2 Randomized, Blinded, Placebo-Controlled Study of DNTH103 in Adults with Generalized Myasthenia Gravis | Dianthus Therapeutics Inc. | Phase II | Not Recruiting | Sep 2024 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dnth103 | 1 | Unknown | 2024-09-03 | 2024-09-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.